Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is [...] to intravenous proton pump inhibitors. Octreotide is most useful in patients with variceal bleeding
Answer
inferior
Question
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is [...] to intravenous proton pump inhibitors. Octreotide is most useful in patients with variceal bleeding
Answer
?
Question
Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is [...] to intravenous proton pump inhibitors. Octreotide is most useful in patients with variceal bleeding
Answer
inferior
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it Octreotide may have a marginal benefit by decreasing the rate of nonvariceal bleeding, but it is inferior to intravenous proton pump inhibitors. Octreotide is most useful in patients with variceal bleeding
Original toplevel document (pdf)
owner: ELBOMBARDO - (no access) - MKSAP_17.pdf, p2594
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.